Immunic, Inc. (IMUX) - Earnings growth in current year
Anticipation of psoriasis test results is driving sector interest as the market awaits commercial revenues from Immunic, Inc. (IMUX). The biotech firm leverages robust R&D capabilities in developing small molecules for sclerosis. A strategy of replacing injections with convenient tablets strengthens the company's position. The annual EPS growth rate on the GURU.Markets chart reflects price adaptation to fundamental data, where 42.70 determines the latest valuation metric.
Analytical breakdowns and data insights for company immunic-therapeutics.com (IMUX)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
- earnings and market ratios statistics:
IMUX - Net Profit|Company Profit Forecast Immunic, Inc.|IMUX - P/E Multiple|Projected Price to Earnings Immunic|IMUX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation IMUX|IMUX - Operating profit EBITDA|Net earnings per share for the last four quarters Immunic|IMUX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months immunic-therapeutics.com|IMUX - Earnings growth in current year|Expected earnings per share growth for next year Immunic, Inc.
Basic company analysis:IMUX, Immunic Inc
Immunic, Inc. is developing therapies for multiple sclerosis while facing intense pressure from pharmaceutical behemoths. Earnings per share (EPS) dynamics measure the percentage change in net income per share relative to the same period last year. This metric allows investors to filter out market volatility and assess the real efficiency of the business's capitalization. Steady growth confirms the company's competitiveness against leading brands. By analyzing the relative EPS growth over 12 months, one can determine the stability of the operating model.
Key competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|Grifols Group - Earnings growth in current year|Expected net earnings per share growth this year Adaptive Biotechnologies Inc. ADPT|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|Net earnings per share growth this year auriniapharma.com|Earnings per share growth in current year BioCryst Pharmaceuticals|Net earnings per share growth this year Vera Therapeutics Inc (VERA)|Net earnings per share growth this year DNTH (Dianthus Pharma)|Earnings growth in current year Pharvaris Pharma (PHVS)|Earnings per share growth in current year AbCellera Biologics ABCL|TRML: Earnings per share growth this year|Precigen - Earnings growth in current year|Expected net earnings per share growth this year Pharming Group NV PHAR|NKTR: Earnings growth in current year|Net earnings per share growth this year Upstream Pharma|Net earnings per share growth this year ZBIO|IMNM: Earnings per share increase in current year|Earnings growth in current year GOSS|Expected net earnings per share growth this year KalVista Pharma|Earnings per share growth in current year Septerna Corp SEPN|PVLA: Earnings per share growth this year|Savara Inc. - Earnings growth in current year|rigel.com (RIGL) - Net earnings per share growth this year|ANAB (AnaptysBio) - Net earnings per share growth this year|ATXS - Expected net earnings per share growth this year|ENGN (enGene Bio) - Earnings growth in current year|RAPT Therapeutics Inc. (RAPT) - Expected net earnings per share growth this year|Earnings per share growth in current year Aerovate Therapeutics Inc (JBIO)|Net earnings per share growth this year aclaristx.com ACRS|Kyverna Therapeutics, Inc. - Net earnings per share growth this year|Earnings growth in current year Tiziana Life Sciences Ltd. TLSA|CABA: Net earnings per share growth this year|VTYX (Ventyx Biosciences, Inc) - Earnings per share growth this year|Theratechnologies Inc. (THTX) - Earnings per share growth in current year|Earnings per share trend in current year AVTX (avalotx.com)|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth in current year|AGEN: Earnings per share increase in current year|Earnings growth in current year CLYM|Earnings growth in current year Zura Bio Ltd (ZURA)|Earnings per share growth in current year aTyr Pharma, Inc. ATYR|Earnings per share increase in current year ADAG|IMA - Earnings per share growth in current year|Shattuck Labs, Inc. (STTK) - Net earnings per share growth this year|EQ: Earnings growth in current year|Connect Biopharma Holdings Limited (CNTB) - Earnings growth in current year|Net earnings per share growth this year ATRA|IFRX: Earnings per share increase in current year|Earnings growth in current year XFOR|Expected net earnings per share growth this year adicetbio.com|Earnings per share growth in current year Celularity CELU|INMB - Net earnings per share growth this year|BRNS - Earnings per share growth in current year|kezarlifesciences.com (KZR) - Net earnings per share growth this year|SABS (SAB Biotherapeutics, Inc.) - Net earnings per share growth this year|Akari Therapeutics PLC (AKTX) - Earnings growth in current year|Earnings per share growth in current year Enlivex Therapeutics Ltd|Earnings per share growth this year QTTB (Q32 Bio Corp)|Earnings growth in current year GOVX|EDSA - Earnings per share growth rate in current year|Earnings growth in current year IBIO (iBio)|Expected net earnings per share growth this year Carisma Therapeutics Inc (CARM)|XTLB - Earnings per share growth in current year|Bolt Biotherapeutics (BOLT) - Net earnings per share growth this year|hcwbiologics.com (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo Therapeutics Inc.|Net earnings per share growth this year AIM|Earnings growth in current year Aditxt Corp|Earnings per share growth in current year GRI Bio Corp (GRI)|XORTX Corp - Earnings per share growth this year|Earnings growth in current year HIND (Vyome Holdings Inc)|Expected net earnings per share growth this year revbiosciences.com (REVB)|Indaptus Therapeutics, Inc. - Earnings growth in current year|Scinai Immunotherapeutics Ltd (SCNI) - Net earnings per share growth this year|CALI (calcimedica.com) - Net earnings per share growth this year|Affimed N.V. - Earnings per share increase in current year|ALLK (Allakos Inc) - Earnings growth in current year|HOOKIPA (HOOK) - Expected net earnings per share growth this year|Earnings per share growth in current year IGM Biosciences, Inc. (IGMS)|iTeos Therapeutics Inc - Earnings per share growth this year|Earnings growth in current year OCEA (Ocean Bio)|TCBP - Net earnings per share growth this year|THRD: Net earnings per share growth this year
